Citi lowers Elastic NV stock price target to $125 from $160

Citi analysts lowered their price target on Elastic NV (ESTC) to $125 from $160 while maintaining a Buy rating, following mixed Q4 results and conservative FY26 guidance attributed to macroeconomic concerns and challenges in the U.S. federal sector; despite this, net revenue retention and billings growth remained stable, and analysts see potential for exceeding guidance, citing reasonable valuation multiples and Generative AI monetization, though other firms have also adjusted targets downwards with mixed ratings due to cloud revenue concerns and longer sales cycles.

Analysis

Elastic NV (ESTC) has experienced a significant price target reduction from Citi analysts to $125 from $160, although a Buy rating was maintained, following a stock decline of over 12% in the past week to near $81. This adjustment reflects mixed fiscal fourth-quarter results, where a weaker federal sector performance led to a smaller-than-anticipated earnings beat, and an initial fiscal year 2026 guidance slightly below consensus, influenced by the new CFO's cautious macroeconomic outlook. Despite this conservatism, InvestingPro data indicates Elastic possesses strong financial health, with more cash than debt and liquid assets surpassing short-term liabilities, and nine analysts have recently revised earnings upwards. Citi observed stable net revenue retention and billings growth, suggesting underlying mid-to-high teens growth, and sees potential for ESTC to exceed its current 11% YoY constant currency growth guidance, supported by reasonable enterprise value to free cash flow multiples and Generative AI monetization opportunities. However, the broader analyst sentiment is mixed: while Q4 FY25 revenues of $388.4 million beat expectations, the FY26 revenue forecast disappointed due to macroeconomic pressures and U.S. public sector challenges. Consequently, other firms like DA Davidson (Neutral, $75), TD Cowen (target $90, citing cloud revenue miss), RBC Capital (Outperform, $115), Wedbush (Outperform, $110), and Cantor Fitzgerald (Neutral, $92) have also adjusted targets, reflecting concerns over cloud business recovery and longer federal sales cycles. Management's optimism regarding sales execution and GenAI contrasts with analyst caution about navigating these headwinds.

Key Decisions for Investors

• Investors should weigh the lowered price targets and conservative guidance against Elastic's strong balance sheet, stable NRR, and Citi's maintained Buy rating, considering the recent share price decline as a potential entry point if fundamental strengths are believed to outweigh near-term headwinds.
• Monitor upcoming earnings reports for signs of recovery in the U.S. federal sector and cloud revenue growth, as well as any revisions to FY26 guidance, which will be critical in assessing the company's ability to outperform current conservative expectations.
• Evaluate the potential impact of Generative AI monetization as a long-term growth catalyst, while remaining cognizant of the persistent macroeconomic uncertainties and specific sector challenges that could temper short-to-medium term performance.